期刊文献+

己酮可可碱对肝纤维化大鼠抗纤维化作用的观察 被引量:3

Antifibrotic effect of pentoxifylline on rat live fibrosis induced by bile duct occlusion
下载PDF
导出
摘要 目的探讨己酮可可碱在胆管阻塞性大鼠肝纤维化模型中的抗纤维化作用。方法雄性SD大鼠60只,分为假手术组、肝纤维化模型组、己酮可可碱组。比较各组肝组织羟脯氨酸含量和组织学评分。结果己酮可可碱组组织评分为2.38分,较模型组(3.5分)显著下降(P﹤0.05)。羟脯氨酸含量模型组[(108.33±14.54)μg/ml]较假手术组[(15.58±4.25)μg/ml]显著升高(P﹤0.05),己酮可可碱组为[(67.50±12.48)μg/ml],与模型组比较下降38%。结论己酮可可碱在大鼠胆管阻塞性肝纤维化模型中具有一定的抗纤维化作用。 Objective To study the antifibrotic effect of pentoxifylline (PTX) on rat fibrosis induced by bile duct occlusion. Methods Sixty male SD rats were divided into three groups: sham-operation group, pathologic model group and PTX group[16mg/(kg·d)]. After 6 weeks of treatment,liver histopathological changes, hydroxyproline(Hyp) content were determined. Results Compared with model group,6 weeks of PTX treatment could reduce the histological scoring and Hyp content. Conclusions In rat fibrosis induced by bile duct occlusion,PTX can attenuate hepatic fibrosis.
出处 《北京医学》 CAS 2010年第7期543-545,共3页 Beijing Medical Journal
关键词 肝纤维化 己酮可可碱 大鼠 Liver fibrosis Pentoxifylline Rat
  • 相关文献

参考文献8

二级参考文献35

  • 1钱燕,范建高,郑晓英,李锋,陆元善.己酮可可碱对高脂饮食大鼠脂肪性肝炎并肝纤维化的干预作用[J].肝脏,2005,10(2):136-137. 被引量:9
  • 2张莉,贾继东,张华,李宝红,孙海梅,曾晓蓓,张立新,王丹,安威.己酮可可碱治疗非乙醇性脂肪性肝炎的实验研究[J].首都医科大学学报,2006,27(3):332-336. 被引量:4
  • 3贾继东 Schuppan D 等.已酮可可减抗实验性肝纤维化的分子生物学机理研究.第十次全国病毒性肝炎会议汇编[M].,2000.98-99.
  • 4Raetsch C, Jia JD, Boigk G, et al. Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut, 2002, 50:241-247.
  • 5Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a doubleblind, placebo-controlled trial. Gastroenterology, 2000, 119: 1637-1648.
  • 6Satapathy SK, Garg S, Chauhan R, et al. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol, 2004, 99:1946-1952.
  • 7Adams LA, Zein CO, Angulo P, et al. A pilot trial of pen: toxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol, 2004, 99:2365-2368.
  • 8Wigg AJ, Roberts-Thomson IC, Dymoek RB, et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut, 2001, 48 : 206-211.
  • 9Haruta I,Tokushige K,Komatsu T,et al.Clinical implication of vascular cell adhesion molecule-1 and very late activation antigen-4 interaction,and matrix metalloproteinase-2 production in patients with liver disease[J].Can J Gastroenterol,1999,13:721-727.
  • 10Preaux A M,Mallat A,Rosonbaum J,et al.Pentoxifylline inhibits growth and collagen synthesis of cultured human hepatic myofibroblast-like cells[J].J Hepatology,1997,26:315-316.

共引文献46

同被引文献46

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部